Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,235 public trials 1,182 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum

NCT00573885

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: British Columbia Cancer Agency - Vancouver Cancer Centre Vancouver, British Columbia, Canada

View Trial Details

Completed

Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung Cancer

NCT00182806

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

NCT00003589

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Algemeen Ziekenhuis Middelheim Antwerp, Belgium

University Hospital Bulovka Krhanice, Czechia

National Cancer Institute of Egypt Cairo, Egypt

CHRU de Nancy - Hopitaux de Brabois Vandœuvre-lès-Nancy, France

View all 33 locations

View Trial Details

Completed

A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of Lung

NCT00816868

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Cancer Center of Sun Yat-Sen University (CCSU) Guangzhou, Guangdong, China

View Trial Details

Completed

A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.

NCT00432562

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +22 more
Locations: Clinical Investigative Site Buenos Aires, Argentina

Clinical Investigative Site Mendoza, Argentina

Clinical Investigative Site Rosario, Argentina

Clinical Investigative Site San Miguel de Tucumán, Argentina

View Trial Details

Completed

Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer

NCT00059605

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: University of Texas M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

NCT00034957

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Research Center Berkeley, California, United States

Research Center Greenbrae, California, United States

Research Center Los Angeles, California, United States

Research Center Rancho Mirage, California, United States

View Trial Details

Completed

A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer

NCT01270386

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Department of Medical Oncology, Cancer Center, Sun Yet-sen University Guangzhou, Guangdong, China

View Trial Details

Completed

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

NCT00900094

Conditions: Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +59 more
Locations: Not specified

View Trial Details

Completed

A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

NCT00138658

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: LAC-USC Medical Center Los Angeles, California, United States

University of Southern California Norris Los Angeles, California, United States

New York Oncology Hematology Albany, New York, United States

Oregon Health and Science University Portland, Oregon, United States

View all 15 locations

View Trial Details